Read More FDA News Alterity Therapeutics Highlights Publication Of Data; Says Data Demonstrates ATH434 Is Neuroprotective And Improves Motor Function By Benzinga Newsdesk Today, 11:05 PM Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today ATHE
Read More Analyst Ratings News Price Target JP Morgan Maintains Overweight on Newell Brands, Raises Price Target to $29 By Benzinga Newsdesk Today, 11:05 PM JP Morgan maintains Newell Brands (NASDAQ:NWL) with a Overweight and raises the price target from $27 to $29. NWL
Read More Analyst Color Analyst Ratings News Price Target Reiteration Small Cap Big Lots’ Negative Q2 Earnings & Softer Q3 Outlook Keep This Analyst On The Sideline By Shivani Kumaresan Today, 11:05 PM Telsey Advisory Group analyst Joseph Feldman reiterated a Market Perform rating on the shares of Big Lots Inc (NYSE:BIG) with a price target… BIG
Read More Analyst Ratings News Price Target Susquehanna Maintains Positive on NVIDIA, Raises Price Target to $265 By Benzinga Newsdesk Today, 11:05 PM Susquehanna analyst Kinngai Chan maintains NVIDIA (NASDAQ:NVDA) with a Positive and raises the price target from $185 to $265. NVDA